596 results on '"Hurt, Aeron C"'
Search Results
102. Performance of influenza rapid point-of-care tests in the detection of swine lineage A(H1N1) influenza viruses
103. Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South Africa
104. Neuraminidase inhibitor drug susceptibility differs between influenza N1 and N2 neuraminidase following mutagenesis of two conserved residues
105. Resistance to anti-influenza drugs: adamantanes and neuraminidase inhibitors
106. In vitro generation and characterisation of an influenza B variant with reduced sensitivity to neuraminidase inhibitors
107. Susceptibility of human influenza viruses from Australasia and South East Asia to the neuraminidase inhibitors zanamivir and oseltamivir
108. Influenza virus A (H10N7) in Chickens and Poultry Abattoir Workers, Australia
109. Influenza and COVID‐19: What does co‐existence mean?
110. Mapping person-to-person variation in viral mutations that escape polyclonal serum targeting influenza hemagglutinin
111. A novel I117T substitution in neuraminidase of highly pathogenic avian influenza H5N1 virus conferring reduced susceptibility to oseltamivir and zanamivir
112. Author response: Mapping person-to-person variation in viral mutations that escape polyclonal serum targeting influenza hemagglutinin
113. Treatment-Emergent Influenza Variant Viruses With Reduced Baloxavir Susceptibility: Impact on Clinical and Virologic Outcomes in Uncomplicated Influenza
114. Circulation and characterization of seasonal influenza viruses in Cambodia, 2012‐2015
115. Antarctic Penguins as Reservoirs of Diversity for Avian Avulaviruses
116. Baloxavir marboxil susceptibility of influenza viruses from the Asia-Pacific, 2012–2018
117. Virome heterogeneity and connectivity in waterfowl and shorebird communities
118. Virus–virus interactions and host ecology are associated with RNA virome structure in wild birds
119. High levels of antibiotic resistance gene expression among birds living in a wastewater treatment plant
120. Animal models used to assess influenza antivirals
121. Influenza A(H5N1) viruses with A(H9N2) single gene (matrix or PB1) reassortment isolated from Cambodian live bird markets
122. A divergent hepatitis D-like agent in birds
123. Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents
124. Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors and status of novel antivirals, 2016–2017
125. The Ongoing Battle Against Influenza: Drug-resistant influenza viruses: why fitness matters
126. Viral burden, inflammatory milieu and CD8+ T‐cell responses to influenza virus in a second‐generation thiazolide (RM‐5061) and oseltamivir combination therapy study.
127. Treatment-Emergent Influenza Variant Viruses With Reduced Baloxavir Susceptibility: Impact on Clinical and Virologic Outcomes in Uncomplicated Influenza.
128. A Review of DNA Vaccines Against Influenza
129. Susceptibility of Brazilian influenza A(H1N1)pdm09 viruses to neuraminidase inhibitors in the 2014–2016 seasons: Identification of strains bearing mutations associated with reduced inhibition profile
130. Circulating T FH cells, serological memory, and tissue compartmentalization shape human influenza-specific B cell immunity
131. The significance of increased influenza notifications during spring and summer of 2010–11 in Australia
132. Fc functional antibodies in humans with severe H7N9 and seasonal influenza
133. Selection of Multi-Drug Resistant Influenza A and B Viruses under Zanamivir Pressure and their Replication Fitness in Ferrets
134. Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals
135. Influenza antivirals currently in late-phase clinical trial
136. Uncomplicated Cystitis in an Adult Male Following Influenza B Virus Infection
137. Assessment of the RNASound RNA Sampling Card for the Preservation of Influenza Virus RNA
138. Evidence for the Introduction, Reassortment, and Persistence of Diverse Influenza A Viruses in Antarctica
139. Reducing disease burden in an influenza pandemic by targeted delivery of neuraminidase inhibitors: mathematical models in the Australian context
140. A Review of the Antiviral Susceptibility of Human and Avian Influenza Viruses over the Last Decade
141. Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2014–2015
142. Using the Ferret as an Animal Model for Investigating Influenza Antiviral Effectiveness
143. Drug-resistant influenza viruses: why fitness matters
144. Zanamivir-resistant influenza viruses with Q136K or Q136R neuraminidase residue mutations can arise during MDCK cell culture creating challenges for antiviral susceptibility monitoring
145. Quantifying relative within-host replication fitness in influenza virus competition experiments
146. Circulating TFH cells, serological memory, and tissue compartmentalization shape human influenza-specific B cell immunity.
147. Human CD8+T cell cross-reactivity across influenza A, B and C viruses
148. Oseltamivir Prophylaxis Reduces Inflammation and Facilitates Establishment of Cross-Strain Protective T Cell Memory to Influenza Viruses
149. A Novel Video Tracking Method to Evaluate the Effect of Influenza Infection and Antiviral Treatment on Ferret Activity
150. Molecular Surveillance of Antiviral Drug Resistance of Influenza A/H3N2 Virus in Singapore, 2009-2013
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.